These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 38790459)

  • 1. A Systematic Review on Autism and Hyperserotonemia: State-of-the-Art, Limitations, and Future Directions.
    Esposito D; Cruciani G; Zaccaro L; Di Carlo E; Spitoni GF; Manti F; Carducci C; Fiori E; Leuzzi V; Pascucci T
    Brain Sci; 2024 May; 14(5):. PubMed ID: 38790459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.
    Chen R; Davis LK; Guter S; Wei Q; Jacob S; Potter MH; Cox NJ; Cook EH; Sutcliffe JS; Li B
    Mol Autism; 2017; 8():14. PubMed ID: 28344757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there sexual dimorphism of hyperserotonemia in autism spectrum disorder?
    Shuffrey LC; Guter SJ; Delaney S; Jacob S; Anderson GM; Sutcliffe JS; Cook EH; Veenstra-VanderWeele J
    Autism Res; 2017 Aug; 10(8):1417-1423. PubMed ID: 28401654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Predictors of Whole Blood Serotonin Levels in Children With or Without Autism.
    Zuniga-Kennedy M; Davoren M; Shuffrey LC; Luna RA; Savidge T; Prasad V; Anderson GM; Veenstra-VanderWeele J; Williams KC
    J Autism Dev Disord; 2022 Sep; 52(9):3780-3789. PubMed ID: 35726077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain hyperserotonemia causes autism-relevant social deficits in mice.
    Tanaka M; Sato A; Kasai S; Hagino Y; Kotajima-Murakami H; Kashii H; Takamatsu Y; Nishito Y; Inagaki M; Mizuguchi M; Hall FS; Uhl GR; Murphy D; Sora I; Ikeda K
    Mol Autism; 2018; 9():60. PubMed ID: 30498565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Serotonin Levels Are Associated With Cognitive Ability and Core Symptoms in Autism Spectrum Disorder.
    Montgomery AK; Shuffrey LC; Guter SJ; Anderson GM; Jacob S; Mosconi MW; Sweeney JA; Turner JB; Sutcliffe JS; Cook EH; Veenstra-VanderWeele J
    J Am Acad Child Adolesc Psychiatry; 2018 Nov; 57(11):867-875. PubMed ID: 30392628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: a study from an Indian population.
    Jaiswal P; Guhathakurta S; Singh AS; Verma D; Pandey M; Varghese M; Sinha S; Ghosh S; Mohanakumar KP; Rajamma U
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():196-206. PubMed ID: 25261775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole Blood Serotonin Levels and Platelet 5-HT
    Aaron E; Montgomery A; Ren X; Guter S; Anderson G; Carneiro AMD; Jacob S; Mosconi M; Pandey GN; Cook E; Veenstra-VanderWeele J
    J Autism Dev Disord; 2019 Jun; 49(6):2417-2425. PubMed ID: 30927179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants of MAOB affect serotonin level and specific behavioral attributes to increase autism spectrum disorder (ASD) susceptibility in males.
    Chakraborti B; Verma D; Karmakar A; Jaiswal P; Sanyal A; Paul D; Sinha S; Singh AS; Guhathakurta S; Roychowdhury A; Panda CK; Ghosh S; Mohanakumar KP; Mukhophadhyay K; Rajamma U
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():123-36. PubMed ID: 27381555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased phenol sulfotransferase activities associated with hyperserotonemia in autism spectrum disorders.
    Pagan C; Benabou M; Leblond C; Cliquet F; Mathieu A; Lemière N; Goubran-Botros H; Delorme R; Leboyer M; Callebert J; Bourgeron T; Launay JM
    Transl Psychiatry; 2021 Jan; 11(1):23. PubMed ID: 33414449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism.
    Coutinho AM; Oliveira G; Morgadinho T; Fesel C; Macedo TR; Bento C; Marques C; Ataíde A; Miguel T; Borges L; Vicente AM
    Mol Psychiatry; 2004 Mar; 9(3):264-71. PubMed ID: 15094787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior.
    Veenstra-VanderWeele J; Muller CL; Iwamoto H; Sauer JE; Owens WA; Shah CR; Cohen J; Mannangatti P; Jessen T; Thompson BJ; Ye R; Kerr TM; Carneiro AM; Crawley JN; Sanders-Bush E; McMahon DG; Ramamoorthy S; Daws LC; Sutcliffe JS; Blakely RD
    Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5469-74. PubMed ID: 22431635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD
    Launay JM; Delorme R; Pagan C; Callebert J; Leboyer M; Vodovar N
    Transl Psychiatry; 2023 Dec; 13(1):380. PubMed ID: 38071324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis.
    Gabriele S; Sacco R; Persico AM
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):919-29. PubMed ID: 24613076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.
    Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S
    Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Levels of 5-HT and BDNF in Adults with Autism Spectrum Conditions: An Investigation in a Sample of Subjects with Autism Spectrum Disorder, their First-degree Relatives and Controls.
    Carpita B; Stagnari R; Palego L; Baroni D; Massimetti G; Nardi B; Cremone IM; Betti L; Giannaccini G; Dell'Osso L
    Curr Med Chem; 2024; 31(6):776-790. PubMed ID: 36718970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-Specific Effect of 5-HT and 5-HIAA on Threshold Level of Behavioral Symptoms and Sex-Bias in Prevalence of Autism Spectrum Disorder.
    Chakraborti B; Verma D; Guhathakurta S; Jaiswal P; Singh AS; Sinha S; Ghosh S; Mukhopadhyay K; Mohanakumar KP; Rajamma U
    Front Neurosci; 2019; 13():1375. PubMed ID: 31998058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endophenotype trait domains for advancing gene discovery in autism spectrum disorder.
    Mosconi MW; Stevens CJ; Unruh KE; Shafer R; Elison JT
    J Neurodev Disord; 2023 Nov; 15(1):41. PubMed ID: 37993779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal issues in autism spectrum disorder.
    Hsiao EY
    Harv Rev Psychiatry; 2014; 22(2):104-11. PubMed ID: 24614765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating Potential Biomarkers in Autism Spectrum Disorder.
    Bridgemohan C; Cochran DM; Howe YJ; Pawlowski K; Zimmerman AW; Anderson GM; Choueiri R; Sices L; Miller KJ; Ultmann M; Helt J; Forbes PW; Farfel L; Brewster SJ; Frazier JA; Neumeyer AM
    Front Integr Neurosci; 2019; 13():31. PubMed ID: 31427932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.